title: [Serotonin syndrome after administration of mirtazapine in a critical care unit].
authors.forename: J
authors.initials: J
authors.lastname: Freijo Guerrero
authors.forename: L
authors.initials: L
authors.lastname: Tardón Ruiz de Gauna
authors.forename: J J
authors.initials: JJ
authors.lastname: Gómez
authors.forename: L
authors.initials: L
authors.lastname: Aguilera Celorrio
mesh_terms: D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D003422:Critical Care; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D020230:Serotonin Syndrome / Q000139:chemically induced*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine